Search Results

Deals

Labcorp Completes Acquisition of Toxikon Corporation

Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract research organization delivering best-in-class nonclinical testing services.

December 3, 2021

·

1 min read

Deals

Labcorp to Acquire Toxikon, Expanding Nonclinical Development Testing Capabilities for Pharmaceutical, Biotech and Medical Device Clients

Labcorp today announced that it has entered into a definitive agreement to acquire Toxikon, a contract research organization delivering best-in-class nonclinical testing services.

November 18, 2021

·

5 min read

Deals

Sterigenics International Acquires Toxikon’s European Laboratory Business

Terms of the deal were not disclosed.

November 1, 2017

·

4 min read

Vyaire Medical Takes Out Revolutionary Medical Dev

Deals

Sterigenics Scoops Up Toxikon’s European Laboratory Biz for Undisclosed Sum

This acquisition provides a more comprehensive service offering and a platform for growth for Sterigenics’ Nelson Labs business.

October 31, 2017

·

4 min read

Business

Toxikon Corporation Forms Partnership with Ocean Ridge BioSciences

November 17, 2011

·

2 min read

Bioprocess Validation Market Size, Growth, Trends | Report 2023-2032

The global bioprocess validation market was estimated at USD 295.02 million in 2022 and it is expected to surpass around USD 971.74 million by 2032, poised to grow at a CAGR of 12.66% from 2023 to 2032.

December 9, 2022

·

4 min read

In-vitro Toxicology Assays Market Size, Share, Growth, Trends, Forecast 2021 to 2030

The global in-vitro toxicology assays market size is expected to be worth around US$ 4.9 billion by 2030, according to a new report by Vision Research Reports.

December 2, 2022

·

5 min read

Bioanalytical Testing Services Market Size Projected to Surpass USD 10.39 Billion By 2032

The global bioanalytical testing services market size is projected to surpass around USD 10.39 billion by 2032, increasing form USD 4.78 billion in 2023 with a remarkable CAGR of 9.02% from 2023 to 2032.

December 7, 2023

·

11 min read

Genetown

Toxikon Corporation Hosts Extractables and Leachables Spring Seminar

March 10, 2010

·

1 min read

Business

New Director of Bioanalytical Services Joins Toxikon Corporation

January 13, 2010

·

1 min read